A.J. Rice

Stock Analyst at UBS

(2.57)
# 830
Out of 5,438 analysts
282
Total ratings
Success rate
Average return
47 Stocks
Name Action PT Current % Upside Ratings Updated
MD Pediatrix Medical Gr...
Maintains: Neutral
16 17
14.12 16.86% 18 Aug 14, 2025
ENSG Ensign Group
Maintains: Strong Buy
185 195
161.78 20.53% 2 Aug 14, 2025
AVAH Aveanna Healthcare H...
Maintains: Sell
5 7
6.83 -1.17% 9 Aug 12, 2025
EHAB Enhabit
Maintains: Neutral
10 9
7.29 16.6% 3 Aug 8, 2025
SEM Select Medical Hldgs
Maintains: Neutral
15 14
12.06 16.09% 8 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
45 31
25.25 22.77% 17 Jul 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
4 4
2.46 30.08% 7 Jul 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
230 238
166.56 42.89% 11 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
484 435
290.83 49.57% 4 Jul 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
19 17
12.68 30.13% 7 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 26
16.48 54.73% 10 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
80 68
62.14 9.43% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
90 88
80.33 9.55% 12 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
38 40
27.85 43.63% 2 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
12 15
14.48 3.59% 11 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 30
20.68 45.07% 4 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
38
22.75 67.03% 1 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
11.37 339.75% 1 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
247 267
171.71 55.49% 13 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 7
n/a n/a 2 Apr 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
250 50
2.3 2073.91% 3 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
450 485
672.98 -27.93% 1 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
95
19.05 398.69% 13 Jul 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
311 316
382.96 -17.48% 12 Jul 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
125 96
64.91 47.9% 6 May 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
62 73
117.42 -37.83% 8 Feb 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
635 575
266.76 115.55% 9 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
38
23.36 62.67% 2 Jan 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
590 610
252.42 141.66% 12 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
308 305
267.87 13.86% 4 Nov 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
64 79
157.91 -49.97% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
175 182
179.98 1.12% 3 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
350 410
153.82 166.55% 3 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
18
16.47 9.29% 1 Oct 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
43 37
4.62 700.87% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
158 143
178.34 -19.82% 9 Jul 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
52 43
11.87 262.26% 7 Jul 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 37
31.33 18.1% 3 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
181 182
100.96 80.27% 5 Apr 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
181 170
169.81 0.11% 4 Mar 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 270
277.03 -2.54% 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
382 425
482.58 -11.93% 7 Apr 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
30.78 -98.15% 3 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
4
n/a n/a 1 Jan 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
207 205
n/a n/a 7 Oct 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
58 65
n/a n/a 5 Jul 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
36 44
n/a n/a 2 Jan 31, 2018